Research Development Solutions was the largest of Iqvia Holdings Inc.’s 3 reported lines in fiscal 2025, at $4.11B — 53% of $7.75B.
| Segment | FY 2012 | FY 2013 | FY 2014 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Research Development Solutions | $3.75B | $4.16B | $3.89B | $4.11B | |||||||||
| Research &Amp; Development Solutions | — | — | — | — | |||||||||
| Technology Analytics Solutions | $2.95B | $3.09B | $3.18B | $3.36B | |||||||||
| Product Development | — | — | — | — | |||||||||
| Integrated Healthcare Services | — | — | — | — | |||||||||
| Integrated Engagement Services | — | — | — | — | |||||||||
| Contract Sales Medical Solutions | $354.00M | $304.00M | $718.00M | $277.00M | |||||||||
| Commercial Solutions | — | — | — | — | |||||||||
| Total | $7.05B | $7.55B | $7.79B | $7.75B |
In fiscal 2025, which ended December 31, 2025, the 3 segments Iqvia Holdings Inc. reported in this breakdown added up to $7.75B. That is less than the $9.27B in its breakdown by region, so these segments do not account for all of its revenue that year. Research Development Solutions was the largest segment, at $4.11B or 53.0% of the total, followed by Technology Analytics Solutions ($3.36B, 43.4%) and Contract Sales Medical Solutions ($277.00M, 3.6%). Together, the two largest segments made up 96.4% of this total.
Compared with fiscal 2024, Technology Analytics Solutions grew the fastest, rising 5.7% to $3.36B. Contract Sales Medical Solutions fell the most, down 61.4% to $277.00M.
The table also keeps 5 segments that Iqvia Holdings Inc. no longer reports, so earlier years can still be read on their original basis; use "Show 5 discontinued" beneath the table to see them. This breakdown covers 13 fiscal years between 2012 and 2025, as reported in Iqvia Holdings Inc.'s annual filings.
Americas was the largest of Iqvia Holdings Inc.’s 3 reported lines in fiscal 2025, at $4.11B — 44% of $9.27B.
| Geography | FY 2011 | FY 2012 | FY 2013 | FY 2014 | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Americas | $3.75B | $4.16B | $3.89B | $4.11B | |||||||||||
| Europe & Africa | $2.18B | $2.16B | $2.40B | $2.65B | |||||||||||
| Asia-Pacific | $2.16B | $2.14B | $2.33B | $2.52B | |||||||||||
| Total | $8.08B | $8.45B | $8.62B | $9.27B |
In fiscal 2025, which ended December 31, 2025, the 3 regions Iqvia Holdings Inc. reported in this breakdown added up to $9.27B. That was up 7.5% from $8.62B in fiscal 2024. Americas was the largest region, at $4.11B or 44.3% of the total, followed by Europe & Africa ($2.65B, 28.5%) and Asia-Pacific ($2.52B, 27.2%). Together, the two largest regions made up 72.8% of this total.
Compared with fiscal 2024, Europe & Africa grew the fastest, rising 10.4% to $2.65B. Every sizeable region reported in both years grew. Over fiscal 2022 to 2025, revenue across these regions went from $8.08B to $9.27B, a compound annual growth rate of 4.7%. Americas' share of the total fell from 46.4% to 44.3% over the same years.
This breakdown covers every fiscal year from 2011 to 2025, as reported in Iqvia Holdings Inc.'s annual filings.
United States was the largest of Iqvia Holdings Inc.’s 4 reported lines in fiscal 2014, at $1.59B — 43% of $3.74B.
| Subsegments | FY 2012 | FY 2013 | FY 2014 |
|---|---|---|---|
| United States | $1.29B | $1.35B | $1.59B |
| Other | $1.09B | $1.14B | $1.28B |
| Japan | $500.28M | $438.88M | $472.00M |
| United Kingdom | $344.85M | $362.24M | $402.00M |
| Total | $3.22B | $3.29B | $3.74B |
In fiscal 2014, which ended December 31, 2014, the 4 segments Iqvia Holdings Inc. reported in this breakdown added up to $3.74B. That was up 13.6% from $3.29B in fiscal 2013. United States was the largest segment, at $1.59B or 42.5% of the total, followed by Other ($1.28B, 34.1%) and Japan ($472.00M, 12.6%). Together, the two largest segments made up 76.6% of this total.
Compared with fiscal 2013, United States grew the fastest, rising 17.6% to $1.59B. Every sizeable segment reported in both years grew. Over fiscal 2012 to 2014, revenue across these segments went from $3.22B to $3.74B, a compound annual growth rate of 7.7%. United States' share of the total rose from 40.0% to 42.5% over the same years.
This breakdown covers every fiscal year from 2012 to 2014, as reported in Iqvia Holdings Inc.'s annual filings.
Iqvia Holdings Inc. (IQV) breaks its revenue down by segment and region. In fiscal 2025, its largest segment was Research Development Solutions, with $4.11B or 53.0% of the total, followed by Technology Analytics Solutions at $3.36B (43.4%).
Research Development Solutions was Iqvia Holdings Inc.'s largest segment in fiscal 2025, with $4.11B in revenue, 53.0% of the $7.75B reported across its 3 segments.
Americas was Iqvia Holdings Inc.'s largest region in fiscal 2025, with $4.11B in revenue, 44.3% of the $9.27B reported across its 3 regions.
Of the Iqvia Holdings Inc. segments reported in both fiscal 2024 and fiscal 2025, and making up at least 2% of the total, Technology Analytics Solutions grew the fastest, rising 5.7% from $3.18B to $3.36B.
Every figure is taken from Iqvia Holdings Inc.'s annual financial filings and shown as reported: each line keeps the name the company gives it, years follow its own fiscal calendar, and lines it has stopped reporting stay in the table for the years they were reported.
The breakdown by segment covers fiscal 2012 to 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.